Le Lézard
Classified in: Health, Covid-19 virus
Subject: SVY

Worldwide Active Pharmaceutical Ingredients Industry to 2026 - Key Drivers, Restraints and Challenges


DUBLIN, July 8, 2020 /PRNewswire/ -- The "Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Global active pharmaceutical ingredients (API) market will reach $293.5 billion by 2026, growing by 7.2% annually over 2020-2026 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.

Highlighted with 91 tables and 99 figures, this 190-page report Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.

Key Players

Key Topics Covered:

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Five Forces Analysis

3 Segmentation of Global Market by Synthesis
3.1 Market Overview by Synthesis
3.2 Synthetic API
3.2.1 Branded Synthetic API
3.2.2 Generic Synthetic API
3.3 Biotech API
3.3.1 Biotech API by Drug Type
3.3.1.1 Monoclonal Antibodies
3.3.1.2 Recombinant Proteins
3.3.1.3 Vaccines
3.3.1.4 Other Biotech APIs
3.3.2 Biotech API by Customer Base
3.3.2.1 Innovative Biologic API
3.3.2.2 Generic Biosimilar API
3.3.3 Biotech API by Expression Technology
3.3.3.1 Mammalian Expression
3.3.3.2 Microbial Expression
3.3.3.3 Yeast Expression
3.3.3.4 Insect Expression
3.3.3.5 Other Expression Technologies
3.4 HPAPI
3.4.1 Branded HPAPI
3.4.2 Generic HPAPI

4 Segmentation of Global Market by Manufacturing Process
4.1 Market Overview by Manufacturing Process
4.2 Captive Manufacturing
4.2.1 Branded Captive API
4.2.2 Generic Captive API
4.3 Merchant Manufacturing
4.3.1 Merchant Manufacturing by Drug Type
4.3.1.1 Branded Merchant API
4.3.1.2 Generic Merchant API
4.3.2 Merchant Manufacturing by Drug Synthesis
4.3.2.1 Merchant Synthetic API
4.3.2.2 Merchant Biotech API

5 Segmentation of Global Market by Therapeutic Application
5.1 Market Overview by Therapeutic Application
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Pulmonary Disorders
5.8 Orthopedics
5.9 Other Applications

6 Segmentation of Global Market by Drug Type
6.1 Market Overview by Drug Type
6.2 Branded Prescription Drugs
6.3 Generic Prescription Drugs
6.4 OTC Drugs

7 Segmentation of Global Market by Region
7.1 Geographic Market Overview 2019-2026
7.2 North America Market 2019-2026 by Country
7.2.1 Overview of North America Market
7.2.2 U.S.
7.2.3 Canada
7.2.4 Mexico
7.3 European Market 2019-2026 by Country
7.3.1 Overview of European Market
7.3.2 UK
7.3.3 France
7.3.4 Germany
7.3.5 Spain
7.3.6 Italy
7.3.7 Russia
7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2019-2026 by Country
7.4.1 Overview of Asia-Pacific Market
7.4.2 China
7.4.3 Japan
7.4.4 India
7.4.5 Australia
7.4.6 South Korea
7.4.7 Rest of APAC Region
7.5 South America Market 2019-2026 by Country
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America Market
7.6 Rest of World Market 2019-2026 by Country
7.6.1 UAE
7.6.2 Saudi Arabia
7.6.3 South Africa
7.6.4 Other National Markets

8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles

9 Investing in Global Market: Risk Assessment and Management
9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/4deivc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 13:23
GBank Financial Holdings Inc. Annual Meeting of Shareholders Scheduled for Tuesday, May 7th at 2:00 P.M. Pacific Time
GBank Financial Holdings Inc. (the "Company") , the parent company for GBank (the "Bank"), today announced it will host its annual meeting of shareholders on Tuesday, May 7, 2024, at 2:00 p.m. (PST). Shareholders will be able to listen from their...

at 12:37
CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Nextdoor Holdings (NYSE: KIND) Investors to Inquire About a Securities Fraud Class Action by April 29, 2024
Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ("Nextdoor" or the "Company") on behalf of purchasers of Nextdoor's securities...

at 12:20
Global Home Infusion Therapy Market Analysis, Trends and Forecasts 2023-2028: Soaring Demand for At-Home Chronic Disease Management, Emerging Potential in Chemotherapy - ResearchAndMarkets.com
The "Global Home Infusion Therapy Market: Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, and Needleless Connectors), By Application, By Route of Administration (Intramuscular, Subcutaneously, and Epidural), By Region Size and...

at 12:15
D.Law Joins L.A. Times Panel to Share Legal Insights
Emil Davtyan, Founder and Managing Attorney at D.Law, recently joined a panel of legal experts to provide insights on the changing landscape of labor and employment issues....

at 12:05
United States Small Household Appliances Markets, 2023-2024 & 2029: Surge in Smart and High-End Product Adoption Amidst Expanding Smart Home Technology - ResearchAndMarkets.com
The "The US Small Household Appliances Market: Analysis By Category, By Product, By Distribution Channel, Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2029" report has been added to ResearchAndMarkets.com's offering. In 2023,...

at 12:00
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nextdoor Holdings
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nextdoor Holdings, Inc. ("Nextdoor" or the "Company") and reminds investors of the April 29, 2024 deadline to seek the role of lead plaintiff in...

More news about Covid-19 virus...


News published on and distributed by: